Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Rachel D Harris und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Methotrexate, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neurotoxicity Syndromes, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health National Cancer Institute, St. Baldrick's Foundation, NCI NIH HHS.
Abstract (Originalsprache)
Methotrexate is a critical component of curative chemotherapy for pediatric acute lymphoblastic leukemia (ALL), but is associated with neurotoxicity. Information on long‐term outcomes following an acute neurotoxic event is limited. Therefore, this report compares neurocognitive performance more than 12 months post diagnosis (mean = 4 years) between ALL patients with ( n = 25) and without ( n = 146) a history of acute neurotoxicity. Compared to children with no documented on‐treatment neurotoxic event, children who experienced a neurotoxic event during treatment exhibited poorer performance on measures of fine motor function ( p = .02) and attention ( p = .02). Children with ALL who experience acute neurotoxicity may be candidates for early neuropsychological screening and intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, Texas, USA.
- Department of Pediatrics, Division of Psychology, Baylor College of Medicine, Houston, Texas, USA.
- Department of Pediatric Psychology and Neuropsychology, Texas Children's Hospital, Houston, Texas, USA.
ORCID-Profile: Rachel D Harris, Kimberly P Raghubar, Mariana Matheus Gonzalez, Mark Zobeck, Austin L Brown
Förderung
- National Institutes of Health National Cancer Institute
- St. Baldrick's Foundation
- NCI NIH HHS
- Cancer Prevention and Research Institute of Texas
- Leukemia Research Foundation Hollis Brownstein Research Grants Program
- St. Baldrick's Foundation Consortium Research Grant
- NICHD NIH HHS
- Leukemia Research Foundation
Zitieren
APA
Harris, R. D., Taylor, O. A., Raghubar, K. P., Matheus Gonzalez, M., Zobeck, M., Gramatges, M. M., Rabin, K. R., Scheurer, M. E., & Brown, A. L. (2024). Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31169
Vancouver
Harris RD, Taylor OA, Raghubar KP, Matheus Gonzalez M, Zobeck M, Gramatges MM, et al. Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31169
BibTeX
@article{Harris2024,
author = {Harris, Rachel D and Taylor, Olga A and Raghubar, Kimberly P and Matheus Gonzalez, Mariana and Zobeck, Mark and Gramatges, M Monica and Rabin, Karen R and Scheurer, Michael E and Brown, Austin L},
title = {Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31169}
}
EUVIMED